Roger Song
Stock Analyst at Jefferies
(2.12)
# 3,222
Out of 5,189 analysts
275
Total ratings
38.4%
Success rate
0.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics | Maintained: Buy | $9 → $8 | $3.23 | +147.68% | 2 | Nov 19, 2026 | |
| INO Inovio Pharmaceuticals | Rated: Buy | $3 → $8 | $1.76 | +354.55% | 5 | Nov 6, 2026 | |
| ABCL AbCellera Biologics | Initiated Coverage: Buy | $21 | $9.69 | +116.72% | 1 | Oct 30, 2026 | |
| ARTV Artiva Biotherapeutics | Downgraded: Hold | $4 | $3.78 | +5.82% | 1 | Oct 28, 2026 | |
| REPL Replimune Group | Rated: Buy | $24 → $29 | $19.07 | +52.07% | 17 | Oct 28, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $146 | $55.39 | +163.59% | 9 | Oct 5, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $121 → $150 | $30.20 | +396.69% | 12 | Oct 1, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $704 | $554.73 | +26.91% | 18 | Oct 1, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $101 | $24.77 | +307.75% | 13 | Sep 23, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $125 | $16.13 | +674.95% | 19 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $182 | $119.52 | +52.28% | 6 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $11.02 | +335.57% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $28.40 | +83.10% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $133 | $95.81 | +38.82% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $21 | $4.28 | +390.65% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 | $63.34 | +31.04% | 6 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $474 | $308.89 | +53.45% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $12.85 | +250.19% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $2.81 | +291.46% | 1 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.919 | +335.26% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $71 | $93.90 | -24.38% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.6277 | +1,493.12% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $2.56 | +603.13% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.9361 | +1,395.57% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $2.03 | +688.18% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $42 | $9.67 | +334.33% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $154 | $75.14 | +104.95% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $6.91 | +305.21% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.21 | n/a | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $40 | $8.60 | n/a | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.5744 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $17 | $3.82 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $4 | $1.06 | n/a | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $49.55 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $1.33 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $0.3278 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.44 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $121.40 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.3855 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.15 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $1.59 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $23.85 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $25 | $7.47 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $3.07 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $13.00 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $27.42 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $142.85 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $0.9893 | n/a | 1 | Apr 29, 2021 |
Prelude Therapeutics
Nov 19, 2026
Maintained: Buy
Price Target: $9 → $8
Current: $3.23
Upside: +147.68%
Inovio Pharmaceuticals
Nov 6, 2026
Rated: Buy
Price Target: $3 → $8
Current: $1.76
Upside: +354.55%
AbCellera Biologics
Oct 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $9.69
Upside: +116.72%
Artiva Biotherapeutics
Oct 28, 2026
Downgraded: Hold
Price Target: $4
Current: $3.78
Upside: +5.82%
Replimune Group
Oct 28, 2026
Rated: Buy
Price Target: $24 → $29
Current: $19.07
Upside: +52.07%
Vaxcyte
Oct 5, 2026
Reiterated: Buy
Price Target: $146
Current: $55.39
Upside: +163.59%
Nektar Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $121 → $150
Current: $30.20
Upside: +396.69%
United Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $704
Current: $554.73
Upside: +26.91%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $101
Current: $24.77
Upside: +307.75%
Structure Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $125
Current: $16.13
Upside: +674.95%
Sep 8, 2026
Reiterated: Buy
Price Target: $182
Current: $119.52
Upside: +52.28%
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $11.02
Upside: +335.57%
Aug 13, 2026
Reiterated: Buy
Price Target: $52
Current: $28.40
Upside: +83.10%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $133
Current: $95.81
Upside: +38.82%
Jul 31, 2026
Reiterated: Buy
Price Target: $62 → $21
Current: $4.28
Upside: +390.65%
Jul 14, 2026
Reiterated: Buy
Price Target: $83
Current: $63.34
Upside: +31.04%
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $308.89
Upside: +53.45%
Jul 8, 2026
Reiterated: Buy
Price Target: $45
Current: $12.85
Upside: +250.19%
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $2.81
Upside: +291.46%
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.919
Upside: +335.26%
Apr 28, 2026
Reiterated: Buy
Price Target: $58 → $71
Current: $93.90
Upside: -24.38%
Apr 15, 2026
Reiterated: Buy
Price Target: $10
Current: $0.6277
Upside: +1,493.12%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $2.56
Upside: +603.13%
Mar 23, 2026
Reiterated: Buy
Price Target: $14
Current: $0.9361
Upside: +1,395.57%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $2.03
Upside: +688.18%
Jan 22, 2026
Reiterated: Buy
Price Target: $13 → $42
Current: $9.67
Upside: +334.33%
Dec 19, 2025
Reiterated: Buy
Price Target: $154
Current: $75.14
Upside: +104.95%
Dec 10, 2025
Reiterated: Buy
Price Target: $28
Current: $6.91
Upside: +305.21%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $4.21
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: $80 → $40
Current: $8.60
Upside: n/a
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $0.5744
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: $9 → $17
Current: $3.82
Upside: n/a
Aug 20, 2025
Reiterated: Buy
Price Target: $12 → $4
Current: $1.06
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $49.55
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: $28
Current: $1.33
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $10 → $8
Current: $0.3278
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $7
Current: $3.44
Upside: n/a
Apr 10, 2025
Reiterated: Buy
Price Target: $68
Current: $121.40
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.3855
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.15
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $1.59
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $23.85
Upside: n/a
Oct 16, 2024
Reiterated: Buy
Price Target: $31 → $25
Current: $7.47
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $3.07
Upside: n/a
Mar 27, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $13.00
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $27.42
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $142.85
Upside: n/a
Apr 29, 2021
Reiterated: Buy
Price Target: $23
Current: $0.9893
Upside: n/a